cancercarcinomacarecellclinicalcombinationcombinationsdrivingemergingevidencefirstfrontlinegenitourinaryguidelineimmunotherapyincorporationinhibitorkeylinemalignanciesmetastaticpatientrecommendationsrecommendedrenalsecondstrategiestargetedtherapytreatmenturothelial